News Releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
May 5, 2022First quarter revenue growth of 7% year-over-year driven by favorable order timing in OA Pain Management
BEDFORD, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results...
-
Apr 15, 2022
BEDFORD, Mass., April 15, 2022 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on April 1, 2022, Anika...
-
Apr 7, 2022
BEDFORD, Mass., April 7, 2022 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its...
-
Apr 4, 2022
BEDFORD, Mass. — April 4, 2022 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will...
-
Mar 23, 2022Anika is an innovative joint preservation company focused on the early intervention orthopedic continuum of care including OA pain management, regenerative solutions, sports medicine, and bone preserving joint technologies.
BEDFORD, Mass., March 23, 2022 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company, today announced it will showcase its comprehensive joint preservation and...
-
Mar 15, 2022
BEDFORD, Mass., March 15, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that it granted:...
-
Mar 10, 2022
BEDFORD, Mass., March 10, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management...
-
Mar 8, 2022Fourth quarter revenue growth of 10% year-over-year despite COVID headwinds
Fourth quarter revenue growth of 10% year-over-year despite COVID headwinds Full-year 2021 revenue up 13% driven by strong growth in Joint Preservation and Restoration BEDFORD, Mass., March 08,...
-
Feb 11, 2022
BEDFORD, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on February...
-
Feb 8, 2022
BEDFORD, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...